Maternal Variables as Determinant of Fetal Growth: Study Protocol on Customized Fetal Growth Charts in Malaysia (GROW-My)

Frontiers in Medicine

Muhammad Za'im Sahul Hameed¹  Azmi Mohd Tamil¹  Saperi Sulong¹  Rosnah Sutan¹  Zaleha Abdullah Mahdy² 

[1] Department of Community Health, Faculty of Medicine, The National University of Malaysia, Kuala Lumpur, Malaysia;Department of Obstetrics and Gynaecology, Faculty of Medicine, The National University of Malaysia, Kuala Lumpur, Malaysia;

关键词: small for gestational age;    low birth weight;    growth chart;    antenatal monitoring;    fundal height;    symphysiofundal height;   

DOI  :  10.3389/fmed.2021.592462

来源: Frontiers

【 摘 要 】

Adverse perinatal outcomes such as stillbirth, low birth weight and small for gestational age are still reported to be of high prevalence despite advanced healthcare technology and good quality hospital services in Malaysia. The purpose of this study is to create a model to evaluate individualized birth weight customized for maternal characteristics in a Malaysian population. Three phases are involved in designing the customized fetal growth chart (GROW-My). Baseline data is collected from previous pregnancies in the UKM Medical Centre from year 2010 to 2017. Specific maternal attributes were screened for its completeness and validity, namely maternal height and weight at booking, maternal ethnicity and parity, and the baby's birth weight, for all singleton pregnancies. The design and construction of a Malaysian customized fetal growth chart, Growth Related Optimal Weight (GROW-MY) was based on baseline birth data. The customized chart is used in the implementation phase for testing its feasibility, taking into consideration feedback from caregivers and patients before and after implementation. The current study provides staunch information and data regarding the needs and strategies for using maternal variables for estimating birth weight and the risk of being small for gestational age, in order to facilitate screening and appropriate management. With improved diagnosis of fetal growth restriction, medical care and treatment costs can be reduced.

【 授权许可】

CC BY